ImmunoGen Announces Webcasts Of Presentations At Upcoming Investor Conferences

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

•Canaccord Genuity Growth Conference

1:30pm ET, August 10, 2016

Back to news